Photo of Robert S. Stern,  MD

Robert S. Stern, MD

Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center
Phone: (617) 667-4995
Fax: (617) 667-4948


rstern@bidmc.harvard.edu

Robert S. Stern, MD

Beth Israel Deaconess Medical Center

EDUCATIONAL TITLES

  • Carl J. Herzog Professor of Dermatologly, Dermatology, Harvard Medical School
  • Chairman, Dermatology, Beth Israel Deaconess Medical Center

DF/HCC PROGRAM AFFILIATION

Research Abstract

My clinical research interests include the epidemiology of both melanoma and non-melanoma skin cancer and the treatment of skin cancer, particularly non-melanoma skin cancer. I am also involved in the treatment of cutaneous T-cell lymphoma and its precursors. In addition, I participate in teaching and patient care related to the above topics.

Publications

Powered by Harvard Catalyst
  • Wu PA, Stern RS. How likely is another nonmelanoma skin cancer?: better informing patients and clinicians. JAMA Dermatol 2015; 151:369-70. PubMed
  • Stern RS. Recurrence of Stevens-Johnson syndrome and toxic epidermal necrolysis. JAMA 2014; 312:1590-1. PubMed
  • Stern RS. Cost effectiveness of Mohs micrographic surgery. J Invest Dermatol 2013; 133:1129-31. PubMed
  • Roujeau JC, Mockenhaupt M, Tahan SR, Henshaw J, Martin EC, Harding M, van Baelen B, Bengtsson L, Singhal P, Kauffman RS, Stern RS. Telaprevir-Related Dermatitis. Arch Dermatol 2012. PubMed
  • Curiel-Lewandrowski C, Nijsten T, Gomez ML, Hollestein LM, Atkins MB, Stern RS. Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study. J Invest Dermatol 2011. PubMed
  • Stern RS. Poor metrics and lost opportunity. J Am Acad Dermatol 2010; 63:718-9. PubMed
  • Stern RS. Prevalence of a history of skin cancer in 2007: results of an incidence-based model. Arch Dermatol 2010; 146:279-82. PubMed
  • Stern RS. Putting Iatrogenic Risk in Perspective: Basal Cell Cancer in PUVA Patients and Australians. J Invest Dermatol 2009; 129:2315-6. PubMed
  • Nijsten T,Spuls P,Stern RS. STROBE: a Beacon for observational studies. Arch Dermatol 2008; 144:1200-4. PubMed
  • Martin DC, Atmuri V, Hemming RJ, Farley J, Mort JS, Byers S, Hombach-Klonisch S, Stern R, Triggs-Raine BL. A mouse model of human Mucopolysaccharidosis IX exhibits osteoarthritis. Hum Mol Genet 2008; 17:1904-15. PubMed
  • Hubbard EJ, Santini V, Blankevoort CG, Volkers KM, Barrup MS, Byerly L, Chaisson C, Jefferson AL, Kaplan E, Green RC, Stern RA. Clock drawing performance in cognitively normal elderly. Arch Clin Neuropsychol 2008; 23:295-327. PubMed
  • Stern R, Maibach HI. Hyaluronan in skin: aspects of aging and its pharmacologic modulation. Clin Dermatol 2008; 26:106-22. PubMed
  • Ashendorf L, Jefferson AL, O'Connor MK, Chaisson C, Green RC, Stern RA. Trail Making Test errors in normal aging, mild cognitive impairment, and dementia. Arch Clin Neuropsychol 2008; 23:129-37. PubMed
  • Posternak M, Novak S, Stern R, Hennessey J, Joffe R, Prange A Jr, Zimmerman M. A pilot effectiveness study: placebo-controlled trial of adjunctive L-triiodothyronine (T3) used to accelerate and potentiate the antidepressant response. Int J Neuropsychopharmacol 2007; 11:15-25. PubMed
  • Karagas MR, Stukel TA, Umland V, Tsoukas MM, Mott LA, Sorensen HT, Jensen AO, Nelson HH, Spencer SK, Perry AE, Stern RS. Reported use of photosensitizing medications and basal cell and squamous cell carcinoma of the skin: results of a population-based case-control study. J Invest Dermatol 2007; 127:2901-3. PubMed
  • Pirmohamed M, Arbuckle JB, Bowman CE, Brunner M, Burns DK, Delrieu O, Dix LP, Twomey JA, Stern RS. Investigation into the multidimensional genetic basis of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 2007; 8:1661-91. PubMed
  • Stern RS. Chronic medication use and inflammatory skin diseases: the power and limitations of the case-control study. J Invest Dermatol 2007; 127:2709-10. PubMed
  • Stern R, Kogan G, Jedrzejas MJ, Soltes L. The many ways to cleave hyaluronan. Biotechnol Adv 2007; 25:537-57. PubMed
  • Nijsten T, Looman CW, Stern RS. Clinical severity of psoriasis in last 20 years of PUVA study. Arch Dermatol 2007; 143:1113-21. PubMed
  • Stern RS. Psoralen and ultraviolet a light therapy for psoriasis. N Engl J Med 2007; 357:682-90. PubMed
  • Malanos D, Stern RS. Psoralen plus ultraviolet A does not increase the risk of cataracts: a 25-year prospective study. J Am Acad Dermatol 2007; 57:231-7. PubMed
  • Jones-Caballero M, Unaeze J, Penas PF, Stern RS. Use of biological agents in patients with moderate to severe psoriasis: a cohort-based perspective. Arch Dermatol 2007; 143:846-50. PubMed
Hide